Publication | Open Access

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Hematological MalignancyMedicineHematologyClinical TrialsMyeloid NeoplasiaMultiple MyelomaLow-dose DexamethasoneOncologyRadiation OncologyHigh-dose Dexamethasone VersusHealth Sciences